FI69839C - Foerfarande foer framstaellning av terapeutiskt aktiva difenylmetoxialkylpiperazinderivat - Google Patents

Foerfarande foer framstaellning av terapeutiskt aktiva difenylmetoxialkylpiperazinderivat Download PDF

Info

Publication number
FI69839C
FI69839C FI773786A FI773786A FI69839C FI 69839 C FI69839 C FI 69839C FI 773786 A FI773786 A FI 773786A FI 773786 A FI773786 A FI 773786A FI 69839 C FI69839 C FI 69839C
Authority
FI
Finland
Prior art keywords
group
formula
same
piperazine
halogen atom
Prior art date
Application number
FI773786A
Other languages
English (en)
Finnish (fi)
Other versions
FI69839B (fi
FI773786A (fi
Inventor
Johan Gootjes
Original Assignee
Gist Brocades Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gist Brocades Nv filed Critical Gist Brocades Nv
Publication of FI773786A publication Critical patent/FI773786A/fi
Publication of FI69839B publication Critical patent/FI69839B/fi
Application granted granted Critical
Publication of FI69839C publication Critical patent/FI69839C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI773786A 1976-12-14 1977-12-14 Foerfarande foer framstaellning av terapeutiskt aktiva difenylmetoxialkylpiperazinderivat FI69839C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB5222376 1976-12-14
GB52223/76A GB1545094A (en) 1976-12-14 1976-12-14 Piperazine derivatives

Publications (3)

Publication Number Publication Date
FI773786A FI773786A (fi) 1978-06-15
FI69839B FI69839B (fi) 1985-12-31
FI69839C true FI69839C (fi) 1986-05-26

Family

ID=10463103

Family Applications (1)

Application Number Title Priority Date Filing Date
FI773786A FI69839C (fi) 1976-12-14 1977-12-14 Foerfarande foer framstaellning av terapeutiskt aktiva difenylmetoxialkylpiperazinderivat

Country Status (22)

Country Link
US (2) US4202896A (da)
JP (1) JPS5382789A (da)
AT (1) AT363090B (da)
AU (1) AU516920B2 (da)
BE (1) BE861853A (da)
DE (1) DE2755752A1 (da)
DK (1) DK147421C (da)
ES (6) ES465047A1 (da)
FI (1) FI69839C (da)
GB (1) GB1545094A (da)
HU (1) HU177999B (da)
IE (1) IE46278B1 (da)
IL (1) IL53597A0 (da)
IT (1) IT1093045B (da)
LU (1) LU78686A1 (da)
NL (1) NL7713817A (da)
NO (1) NO148150C (da)
NZ (1) NZ185981A (da)
PT (1) PT67400B (da)
SE (1) SE435378B (da)
YU (1) YU295877A (da)
ZA (1) ZA777452B (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3167049D1 (de) * 1980-06-16 1984-12-13 Ferrosan Ab Diphenylbutyl-1-acylpiperazines
NL8202636A (nl) * 1982-06-29 1984-01-16 Gist Brocades Nv Piperazinederivaten, werkwijzen ter bereiding daarvan en farmaceutische preparaten die deze verbindingen bevatten.
DE3600390A1 (de) * 1986-01-09 1987-07-16 Hoechst Ag Diarylalkyl-substituierte alkylamine, verfahren zu ihrer herstellung, ihre verwendung sowie sie enthaltende arzneimittel
US5162537A (en) * 1986-04-17 1992-11-10 Monsanto Company Benzhydryl compounds as herbicide antidotes
HU196194B (en) * 1986-04-28 1988-10-28 Richter Gedeon Vegyeszet Process for producing new 1-4 disubstituted piperazines and pharmaceuticals comprising the compounds
HU196196B (en) * 1986-04-28 1988-10-28 Richter Gedeon Vegyeszet Process for producing new benzhydryl-piperazine derivatives and pharmaceuticals comprising the compounds
HU196195B (en) * 1986-04-28 1988-10-28 Richter Gedeon Vegyeszet Process for producing 1,4-disubstituted piperazine derivatives and pharmaceuticals comprising the compounds
FR2601366B1 (fr) * 1986-07-10 1988-11-25 Andre Buzas Derives de la benzhydryloxyethyl-piperazine, procedes d'obtention et de compositions pharmaceutiques les contenant.
FR2636946B1 (fr) * 1988-09-23 1990-11-02 Lipha ((diarylmethoxy)alcoyl)-1 pyrrolidines et piperidines, procedes de preparation et medicaments les contenant
US5153198A (en) * 1989-03-15 1992-10-06 Santen Pharmaceutical Co., Ltd. Agent for treatment of disorders of the cerebro-neural transmission system
US5087627A (en) * 1989-03-15 1992-02-11 Santen Pharmaceutical Co., Ltd. Agent for treatment of disorders of the cerebro-neural transmission system
FR2661176B1 (fr) * 1990-04-20 1992-06-12 Adir Nouveau procede de preparation de la 1-(2,3,4-trimethoxybenzyl) piperazine en amination reductive.
US5276035A (en) * 1990-07-26 1994-01-04 Novo Nordisk A/S 1,4-disubstituted piperazines
DK178490D0 (da) * 1990-07-26 1990-07-26 Novo Nordisk As 1,4-disubstituerede piperaziner
WO1993000811A1 (en) * 1991-07-01 1993-01-21 The General Hospital Corporation Invertebrate phenylethanolamine transporter and the use thereof
US5747493A (en) * 1993-06-25 1998-05-05 Pola Chemical Industries, Inc. Dopamine re-uptake inhibitor
DK1257541T3 (da) * 2000-01-11 2009-01-19 Molecular Insight Pharm Inc Farmakoforiske stoffer
US6743797B2 (en) * 2002-02-22 2004-06-01 Chantest, Inc. Methods for treating cardiac arrhythmia
US7211407B2 (en) * 2003-07-15 2007-05-01 Chan Test, Inc. High throughput assay systems and methods for identifying agents that alter surface expression of integral membrane proteins
US20050054010A1 (en) * 2003-07-15 2005-03-10 Brown Arthur M. High throughput assay systems and methods for identifying agents that alter surface expression of integral membrane proteins
US20050208595A1 (en) * 2004-03-19 2005-09-22 Brown Arthur M High throughput assay systems and methods for identifying agents that alter expression of cellular proteins
FR2884712B1 (fr) * 2005-04-21 2007-06-15 Oreal Compositions cosmetiques comprenant des derives de piperazine
JP5121707B2 (ja) 2005-07-04 2013-01-16 ハイ ポイント ファーマシューティカルズ，エルエルシー 新規医薬
JP2009537596A (ja) * 2006-05-23 2009-10-29 ハイ ポイント ファーマシューティカルズ，リミティド ライアビリティ カンパニー ６−（４−シクロプロピルピペリジン−１−イル）−２’−メチル−［３，４’］−ビピリジン及びその医薬としての使用
SG163547A1 (en) * 2006-05-29 2010-08-30 High Point Pharmaceuticals Llc 3- (1, 3-benz0di0x0l-5-yl) -6- (4-cyclopropylpiperazin-1-yl) -pyridazine, its salts and solvates and its use as histamine h3 receptor antagonist
EP2014656A3 (en) * 2007-06-11 2011-08-24 High Point Pharmaceuticals, LLC New heteocyclic h3 antagonists
US20120028992A1 (en) * 2010-08-02 2012-02-02 Brown Arthur M Pharmaceutical compositions for terminating acute episodes of cardiac arrhythmia, restoring sinus rhythm, preventing recurrence of cardiac arrhythmia and/or maintaining normal sinus rhythm in mammals
CN104529942B (zh) * 2014-12-10 2018-05-15 天津孚音生物科技发展有限公司 一种伐诺司林的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB837986A (en) 1956-07-10 1960-06-22 Henri Morren New piperazine derivatives and process for the preparation thereof
US2953568A (en) * 1958-03-03 1960-09-20 Ciba Pharm Prod Inc Derivatives of piperazine
CH410961A (de) * 1961-02-22 1966-04-15 Yoshitomi Pharmaceutical Verfahren zur Herstellung N-substituierter Piperazinderivate
DE1445692A1 (de) 1963-03-25 1969-03-20 Egyt Gyogyszervegyeszeti Gyar Verfahren zur Herstellung von Piperazinderivaten
DE1795375A1 (de) * 1968-09-21 1972-01-05 Boehringer Mannheim Gmbh Basische AEther und Verfahren zur Herstellung derselben
JPS504086A (da) * 1973-01-18 1975-01-16

Also Published As

Publication number Publication date
FI69839B (fi) 1985-12-31
SE435378B (sv) 1984-09-24
ATA891177A (de) 1980-12-15
NO774307L (no) 1978-06-15
GB1545094A (en) 1979-05-02
YU295877A (en) 1983-01-21
NL7713817A (nl) 1978-06-16
JPS5382789A (en) 1978-07-21
DE2755752A1 (de) 1978-06-15
PT67400B (en) 1979-05-21
NO148150C (no) 1983-08-24
AU516920B2 (en) 1981-07-02
SE7714184L (sv) 1978-06-15
IE46278B1 (en) 1983-04-20
ES465047A1 (es) 1979-01-01
JPS6215546B2 (da) 1987-04-08
FI773786A (fi) 1978-06-15
BE861853A (fr) 1978-06-14
ES473815A1 (es) 1979-05-01
US4202896A (en) 1980-05-13
ZA777452B (en) 1978-10-25
LU78686A1 (da) 1978-04-17
DE2755752C2 (da) 1991-12-05
AU3157377A (en) 1979-06-21
IE46278L (en) 1978-06-14
AT363090B (de) 1981-07-10
PT67400A (en) 1978-01-01
ES473817A1 (es) 1979-04-16
IL53597A0 (en) 1978-03-10
IT1093045B (it) 1985-07-19
NO148150B (no) 1983-05-09
DK147421B (da) 1984-07-30
DK147421C (da) 1985-02-11
ES473816A1 (es) 1979-04-16
HU177999B (en) 1982-02-27
ES473818A1 (es) 1979-04-16
DK557277A (da) 1978-06-15
NZ185981A (en) 1980-02-21
US4265894A (en) 1981-05-05
ES473814A1 (es) 1979-04-16

Similar Documents

Publication Publication Date Title
FI69839C (fi) Foerfarande foer framstaellning av terapeutiskt aktiva difenylmetoxialkylpiperazinderivat
US3974158A (en) 2-(Substituted anilino)methylmorpholines
CH521355A (de) Verfahren zur Herstellung von aromatischen Äthern
US4457931A (en) Piperazine derivatives with anticholinergic and/or antihistaminic activity
EP0483932A1 (en) Process for the preparation of piperazine derivatives
US4077999A (en) Novel oxime ethers
AU617530B2 (en) (diarylmethoxy)-1-pyrrolidines and-piperidines
IL98696A (en) 1,4-disubstituted piperazines their preparation and pharmaceutical compositions containing them
EP0008645B1 (de) Alkoxyphenylpyrrolidone, Verfahren zu ihrer Herstellung und Arzneimittel auf Basis dieser Verbindungen
JPS62230767A (ja) アセトアミド誘導体、その製造方法およびその医薬への応用
CH644582A5 (fr) Amides d'acide polyprenylcarboxylique.
SE464707B (sv) Nya 2-(difenylmetylpiperazinyl)-1-fenyletanol-derivat, foerfarande foer deras framstaellning samt farmaceutiskt preparat
US4515944A (en) 1,5-Diphenyl-2-haloalkylpyrazolin-3-one intermediates
EP0243905B1 (de) 1(omega-[bis-(Phenyl)-alkoxy]-alkyl)-4-(di-(phenyl)-methyl)- Piperazine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
EP0065295A1 (de) Substituierte Tryptaminderivate von Thienyloxypropanolaminen, Verfahren zu ihrer Herstellung, pharmazeutische Präparate auf Basis dieser Verbindungen sowie ihre Verwendung
HU199774B (en) Process for production of derivatives of amin-alcohol and medical compositions containing them as active substance
FI85466C (fi) Foerfarande foer framstaellning av foer behandling av spasmodiska tillstaond och allergier anvaendbara benzhydryloxietylpiperidinderivat.
US3135756A (en) Table ii
US4008265A (en) Novel bisphenoxy carboxylic acid derivatives and their salts
DE2318273C3 (de) Basisch substituierte 13-Benzodioxolderivate und deren pharmakologisch verträgliche Salze sowie diese Verbindungen enthaltende Arzneimittel
HU192589B (en) Process for producing 2-/n-pyrrolidino/-3-isobuthyloxy-n-/substituted phenyl/-n-benzyl-propyl-amines and acid additional salts thereof
US4622322A (en) Aroyl substituted dihydro-1,4-thiazines
DK151254B (da) Analogifremgangsmaade til fremstilling af 2-hydroxymethyl-pyrazin-derivater eller farmaceutisk acceptable salte deraf
JP2013032380A (ja) ピログルタミン酸塩並びにデキストロセチリジン及びレボセチリジンの合成のための中間体の光学分割におけるその使用
NO860465L (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkanolaminderivater.

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: BROCADES PHARMA B. V.